Despite the role of ANG-2 and the VEGF in the clinical setting of HCC and CCA being well described, the direct effect of ANG-2 and the VEGF, alone or together, on liver malignant cells in vitro has not been well elucidated. Here, VEGFA is linked to hepatocellular carcinoma.